Literature DB >> 3883262

Amniotic fluid glucose values in normal and abnormal pregnancies.

P A Weiss, H Hofmann, R Winter, P Pürstner, W Lichtenegger.   

Abstract

Glucose values were determined in 102 urine samples of newborn infants and in 2295 amniotic fluid (AF) samples of women between the 14th and 42nd week of pregnancy. One thousand, six hundred fifty-five of the AF samples derived from normal pregnancies, 50 from pregnancies with fetal malformations, 115 from cases of hydramnios, 246 from pregnant women with an abnormal oral glucose tolerance test, and 230 from insulin-dependent diabetics. Mean AF glucose concentration rises slightly between the 14th and 17th week of pregnancy, decreasing from 46 to about 16 mg% at the end of pregnancy. In cases of fetal malformations, 68% of the glucose levels was below the tenth percentile of normal values. Hydramnios showed no deviation from normal values. In patients with abnormal glucose tolerance, AF glucose increased by a total of 42% and by 67% in fetal hyperinsulinism. Insulin-dependent diabetics had glucose values elevated by a total of 77% and by 106% in fetal hyperinsulinism. The AF glucose profile reflects the level of maternal blood glucose that is transported to the fetus and excreted in the fetal urine as a major source of glucose in AF.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3883262

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Falling insulin requirement in late pregnancy: association with obstetric and neonatal outcomes.

Authors:  Barbara Wilkinson; Marie McDonnell; Nadine Palermo; Sarah Lassey; Sarah Little
Journal:  J Perinatol       Date:  2021-03-04       Impact factor: 2.521

2.  Immunohistochemical localization of glucose transporters and insulin receptors in human fetal membranes at term.

Authors:  H J Wolf; G Desoye
Journal:  Histochemistry       Date:  1993-11

3.  More than fetal urine: enteral uptake of amniotic fluid as a major predictor for fetal growth during late gestation.

Authors:  Soyhan Bagci; Erwin Brosens; Dick Tibboel; Annelies De Klein; Hanneke Ijsselstijn; Charlotte H W Wijers; Nel Roeleveld; Ivo de Blaauw; Paul M Broens; Iris A L M van Rooij; Alice Hölscher; Thomas M Boemers; Marcus Pauly; Oliver J Münsterer; Eberhard Schmiedeke; Mattias Schäfer; Benno E Ure; Martin Lacher; Vera Choinitzki; Johannes Schumacher; Nadine Zwink; Ekkehart Jenetzky; David Katzer; Joerg Arand; Peter Bartmann; Heiko M Reutter
Journal:  Eur J Pediatr       Date:  2016-03-16       Impact factor: 3.183

4.  Fetal exposure to altered amniotic fluid glucose, insulin, and insulin-like growth factor-binding protein 1 occurs before screening for gestational diabetes mellitus.

Authors:  Daniel K Tisi; David H Burns; Gary W Luskey; Kristine G Koski
Journal:  Diabetes Care       Date:  2010-09-20       Impact factor: 19.112

5.  Amniotic fluid glucose concentration: a marker for infection in preterm labor and preterm premature rupture of membranes.

Authors:  G A Dildy; M D Pearlman; L G Smith; G Tortolero-Luna; S Faro; D B Cotton
Journal:  Infect Dis Obstet Gynecol       Date:  1994
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.